Zhi Chai
Jinzhong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
The association between academic emotions and self-efficacy among nursing undergraduates: a cross-sectional regression analysis.
Journal: Frontiers in psychology
Published: June 06, 2026
Mechanism analysis of MPTP-induced Parkinson's disease-like pathology via the HPA axis-microglial glucocorticoid receptor pathway.
Journal: Ecotoxicology and environmental safety
Published: April 16, 2026
Hyperoside Exerts Therapeutic Effects on Parkinson's Disease by Mitigating Oxidative Stress through Activation of Nrf2/HO-1 Pathway.
Journal: Chinese journal of integrative medicine
Published: February 09, 2026
Dual isoflavone and carboxyl-containing compound profiling for antioxidant evaluation of fermented soybean products.
Journal: Food research international (Ottawa, Ont.)
Published: January 27, 2026
Astragaloside IV alleviates motor and anxiety deficits in Parkinson's disease mice by targeting TLR4.
Journal: International immunopharmacology
Published: November 14, 2025
Cycloastragenol Derivatives Improve Tyrosine Metabolism, Regulate TLR4/NF-κB/TERT Signaling Pathways, and Inhibit MPTP Induced Neuroinflammation and PD Symptoms.
Journal: CNS neuroscience & therapeutics
Published: October 13, 2025
Assessment of the structural characterization and anti-inflammatory activities of various parts of Astragalus (root, stem, leaf, flower) from a polysaccharide perspective.
Journal: International journal of biological macromolecules
Published: October 09, 2025
Wuzi Yanzong Pill improves Parkinson's disease via miR-146a-5p/USP3/NF-κB axis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 05, 2025
Qizhi Tongluo capsule improves vascular dementia in rats via integrated metabolomics and molecular mechanism research.
Journal: Journal of ethnopharmacology
Published: September 26, 2025
Mechanism analysis of rotenone toxic exposure inducing neurotoxicity through the MAPK/MMPs signaling pathway.
Journal: Ecotoxicology and environmental safety
Published: April 24, 2025
Astragaloside IV ameliorates Parkinson's disease by inhibiting TLR4/NF-κB-dependent neuroinflammation.
Journal: International immunopharmacology
Published: January 19, 2025
Effects of electroacupuncture on HMGB1/RAGE/NF-κB pathway-mediated inflammatory response and reactive astrocyte in Parkinson's disease mice
Journal: Zhongguo zhen jiu = Chinese acupuncture & moxibustion
Published: December 18, 2024
Last Updated: 09/26/2026